Jefferies upgrades Molbio Diagnostics to Buy with ₹1,600 target

Statements (4)

1. ▲ Bullish

   Jefferies assigned a ‘Buy’ rating to Molbio Diagnostics with a target price of ₹1,600 indicating over 98% upside potential

   livemint.comOct 1, 2026 04:37 UTC
2. ▲ Bullish

   Jefferies set a Rs 1,600 target price for Molbio Diagnostics, implying 27% upside from the recent close and nearly 98% above its Rs 807 IPO price

   economictimes.indiatimes.comSep 30, 2026 05:54 UTC
3. ▲ Bullish

   Molbio Diagnostics shares rallied 9% after Jefferies initiated coverage with a Buy rating and named it a high-conviction top pick

   economictimes.indiatimes.comSep 30, 2026 05:54 UTC
4. ▲ Bullish

   Jefferies assigned a 'Buy' rating to Molbio and set a target price of ₹1,600, indicating a 27% upside from its last closing price of ₹1255.60

   business-standard.comSep 30, 2026 04:23 UTC